Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy
NCT ID: NCT00715546
Last Updated: 2011-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
5 participants
INTERVENTIONAL
2007-10-31
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety Study of Local Administration of Autologous Bone Marrow Stromal Cells in Chronic Paraplegia
NCT01909154
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease
NCT01302015
Adipose Derived Stem Cell Therapy for Autism
NCT01502488
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head
NCT01643655
Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Type 2 Diabetics
NCT00703612
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
autologous transplantation of liposuction material enriched with adipose-derived stem cells
Lipoinjection enriched with adipose-derived stem-cells.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* accept to participate of the study
Exclusion Criteria
* Metastatic malignancy
* Body mass index \< 20 kg/m²
* Other severe systemic disease
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Irmandade Santa Casa de Misericórdia de Porto Alegre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Irmandade Santa Casa de Misericórdia de Porto Alegre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eduardo M. Chem, MD
Role: PRINCIPAL_INVESTIGATOR
Irmandade Santa Casa de Misericórdia de Porto Alegre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Irmandade Santa Casa de Misericórdia
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ISCMPA 1642/07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.